JOSE JOAQUIN
PORTU ZAPIRAIN
PROFESORADO ASOCIADO
Publicaciones (34) Publicaciones de JOSE JOAQUIN PORTU ZAPIRAIN
2022
-
Changes in body mass index and clinical outcomes after initiation of contemporary antiretroviral regimens
AIDS (London, England), Vol. 36, Núm. 15, pp. 2107-2119
2021
-
Impact of an enhanced screening program on the detection of non-AIDS neoplasias in patients with human immunodeficiency virus infection
Trials, Vol. 22, Núm. 1
-
Self-rated health among people living with HIV in Spain in 2019: a cross-sectional study
BMC Infectious Diseases, Vol. 21, Núm. 1
2020
-
Impact of HIV on the survival of hepatocellular carcinoma in hepatitis C virus-infected patients
AIDS (London, England), Vol. 34, Núm. 10, pp. 1497-1507
2019
-
Diverse large HIV-1 non-subtype B clusters are spreading among men who have sex with men in Spain
Frontiers in Microbiology, Vol. 10, Núm. APR
-
Low performance of ultrasound surveillance for the diagnosis of hepatocellular carcinoma in HIV-infected patients
AIDS, Vol. 33, Núm. 2, pp. 269-278
2018
-
A case-control study of non-AIDS-defining cancers in a prospective cohort of HIV-infected patients
Medicina Clinica, Vol. 150, Núm. 8, pp. 291-296
-
Aging and the evolution of comorbidities among HIV-positive individuals in a European cohort
AIDS (London, England), Vol. 32, Núm. 16, pp. 2405-2416
-
Hepatocellular carcinoma after sustained virological response with interferon-free regimens in HIV/hepatitis C virus-coinfected patients
AIDS, Vol. 32, Núm. 11, pp. 1423-1430
2017
-
Week 4 response predicts sustained virological response to all-oral direct-acting antiviral-based therapy in cirrhotic patients with hepatitis C virus genotype 3 infection
Clinical Microbiology and Infection, Vol. 23, Núm. 6, pp. 409.e5-409.e8
2015
-
Undetectable HCV-RNA at treatment-week 8 results in high-sustained virological response in HCV G1 treatment-experienced patients with advanced liver disease: The International Italian/Spanish Boceprevir/Peginterferon/Ribavirin Name Patients Program
Journal of Viral Hepatitis, Vol. 22, Núm. 5, pp. 469-480
2012
-
Comparison of high ribavirin induction versus standard ribavirin dosing, plus peginterferon-for the treatment of chronic hepatitis C in HIV-infected patients: The PERICO trial
Journal of Infectious Diseases, Vol. 206, Núm. 6, pp. 961-968
2011
-
Impact of inosine triphosphatase gene variants on the risk of anemia in HIV/Hepatitis C virus-coinfected patients treated for chronic hepatitis C
Clinical Infectious Diseases, Vol. 53, Núm. 12, pp. 1291-1295
2010
-
Factores asociados con la no realización de la prueba de la tuberculina en una cohorte de pacientes VIH positivos
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 28, Núm. 4, pp. 215-221
-
Preemptive erythropoietin plus high ribavirin doses to increase rapid virological responses in HIV patients treated for chronic hepatitis C
AIDS Research and Human Retroviruses, Vol. 26, Núm. 4, pp. 419-424
2009
-
Eligibility for and outcome of treatment of latent tuberculosis infection in a cohort of HIV-infected people in Spain
BMC Infectious Diseases, Vol. 10
-
Long-term effectiveness and safety outcomes in HIV-1-infected patients after a median time of 6 years on nevirapine
Current HIV Research, Vol. 7, Núm. 5, pp. 526-532
-
Nephrogenic systemic fibrosis in a patient with a p-ANCA systemic vasculitis
Reumatologia Clinica, Vol. 5, Núm. 6, pp. 264-267
2008
-
Diabetes mellitus during interferon therapy
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 26, Núm. 2, pp. 120-121